Literature DB >> 26475807

Clinically relevant concentrations of lidocaine and ropivacaine inhibit TNFα-induced invasion of lung adenocarcinoma cells in vitro by blocking the activation of Akt and focal adhesion kinase.

T Piegeler1, M Schläpfer2, R O Dull3, D E Schwartz4, A Borgeat5, R D Minshall6, B Beck-Schimmer7.   

Abstract

BACKGROUND: Matrix-metalloproteinases (MMP) and cancer cell invasion are crucial for solid tumour metastasis. Important signalling events triggered by inflammatory cytokines, such as tumour necrosis factor α (TNFα), include Src-kinase-dependent activation of Akt and focal adhesion kinase (FAK) and phosphorylation of caveolin-1. Based on previous studies where we demonstrated amide-type local anaesthetics block TNFα-induced Src activation in malignant cells, we hypothesized that local anaesthetics might also inhibit the activation and/or phosphorylation of Akt, FAK and caveolin-1, thus attenuating MMP release and invasion of malignant cells.
METHODS: NCI-H838 lung adenocarcinoma cells were incubated with ropivacaine or lidocaine (1 nM-100 µM) in absence/presence of TNFα (20 ng ml(-1)) for 20 min or 4 h, respectively. Activation/phosphorylation of Akt, FAK and caveolin-1 were evaluated by Western blot, and MMP-9 secretion was determined by enzyme-linked immunosorbent assay. Tumour cell migration (electrical wound-healing assay) and invasion were also assessed.
RESULTS: Ropivacaine (1 nM-100 μM) and lidocaine (1-100 µM) significantly reduced TNFα-induced activation/phosphorylation of Akt, FAK and caveolin-1 in NCI-H838 cells. MMP-9 secretion triggered by TNFα was significantly attenuated by both lidocaine and ropivacaine (half-maximal inhibitory concentration [IC50]=3.29×10(-6) M for lidocaine; IC50=1.52×10(-10) M for ropivacaine). The TNFα-induced increase in invasion was completely blocked by both lidocaine (10 µM) and ropivacaine (1 µM).
CONCLUSIONS: At clinically relevant concentrations both ropivacaine and lidocaine blocked tumour cell invasion and MMP-9 secretion by attenuating Src-dependent inflammatory signalling events. Although determined entirely in vitro, these findings provide significant insight into the potential mechanism by which local anaesthetics might diminish metastasis.
© The Author 2015. Published by Oxford University Press on behalf of the British Journal of Anaesthesia. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  anesthetics, local; inflammation; neoplasm metastasis

Mesh:

Substances:

Year:  2015        PMID: 26475807      PMCID: PMC4850926          DOI: 10.1093/bja/aev341

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  32 in total

1.  Ropivacaine decreases inflammation in experimental endotoxin-induced lung injury.

Authors:  Stephan Blumenthal; Alain Borgeat; Thomas Pasch; Livia Reyes; Christa Booy; Maud Lambert; Ralph C Schimmer; Beatrice Beck-Schimmer
Journal:  Anesthesiology       Date:  2006-05       Impact factor: 7.892

2.  Effect of anesthetic technique on serum vascular endothelial growth factor C and transforming growth factor β in women undergoing anesthesia and surgery for breast cancer.

Authors:  Micheal Looney; Peter Doran; Donal J Buggy
Journal:  Anesthesiology       Date:  2010-11       Impact factor: 7.892

3.  Can anesthetic technique for primary breast cancer surgery affect recurrence or metastasis?

Authors:  Aristomenis K Exadaktylos; Donal J Buggy; Denis C Moriarty; Edward Mascha; Daniel I Sessler
Journal:  Anesthesiology       Date:  2006-10       Impact factor: 7.892

Review 4.  Src family kinases as mediators of endothelial permeability: effects on inflammation and metastasis.

Authors:  M P Kim; S I Park; S Kopetz; G E Gallick
Journal:  Cell Tissue Res       Date:  2008-09-25       Impact factor: 5.249

5.  Warm hepatic ischemia-reperfusion promotes growth of colorectal carcinoma micrometastases in mouse liver via matrix metalloproteinase-9 induction.

Authors:  Ian B Nicoud; Christopher M Jones; Janene M Pierce; T Mark Earl; Lynn M Matrisian; Ravi S Chari; D Lee Gorden
Journal:  Cancer Res       Date:  2007-03-15       Impact factor: 12.701

6.  Long-term survival after colon cancer surgery: a variation associated with choice of anesthesia.

Authors:  Rose Christopherson; Kenneth E James; Mara Tableman; Prudence Marshall; Frank E Johnson
Journal:  Anesth Analg       Date:  2008-07       Impact factor: 5.108

Review 7.  Src signaling in cancer invasion.

Authors:  Marcello Guarino
Journal:  J Cell Physiol       Date:  2010-04       Impact factor: 6.384

8.  Endothelial barrier disruption by VEGF-mediated Src activity potentiates tumor cell extravasation and metastasis.

Authors:  Sara Weis; Jianhua Cui; Leo Barnes; David Cheresh
Journal:  J Cell Biol       Date:  2004-10-25       Impact factor: 10.539

9.  Loss of stromal caveolin-1 expression: a novel tumor microenvironment biomarker that can predict poor clinical outcomes for pancreatic cancer.

Authors:  Tao Shan; Hongwei Lu; Hong Ji; Yiming Li; Jian Guo; Xi Chen; Tao Wu
Journal:  PLoS One       Date:  2014-06-20       Impact factor: 3.240

10.  Overcoming EMT-associated resistance to anti-cancer drugs via Src/FAK pathway inhibition.

Authors:  Catherine Wilson; Katrina Nicholes; Daisy Bustos; Eva Lin; Qinghua Song; Jean-Philippe Stephan; Donald S Kirkpatrick; Jeff Settleman
Journal:  Oncotarget       Date:  2014-09-15
View more
  29 in total

1.  Lidocaine inhibits the proliferation of lung cancer by regulating the expression of GOLT1A.

Authors:  Lei Zhang; Rong Hu; Yanyong Cheng; Xiaoyang Wu; Siwei Xi; Yu Sun; Hong Jiang
Journal:  Cell Prolif       Date:  2017-07-24       Impact factor: 6.831

Review 2.  [Systemic effects of amide-linked local anesthetics : Old drugs, new magic bullets?]

Authors:  T Piegeler; R Werdehausen
Journal:  Anaesthesist       Date:  2018-07       Impact factor: 1.041

3.  The Amide Local Anesthetic Ropivacaine Attenuates Acute Rejection After Allogeneic Mouse Lung Transplantation.

Authors:  Tatsuo Maeyashiki; Jae-Hwi Jang; Florian Janker; Yoshito Yamada; Ilhan Inci; Walter Weder; Tobias Piegeler; Wolfgang Jungraithmayr
Journal:  Lung       Date:  2019-02-09       Impact factor: 2.584

4.  Ropivacaine inhibits tumor angiogenesis via sodium-channel-independent mitochondrial dysfunction and oxidative stress.

Authors:  Jingwen Yang; Guangting Li; Kaibei Bao; Weihua Liu; Yaozhi Zhang; Weijen Ting
Journal:  J Bioenerg Biomembr       Date:  2019-03-07       Impact factor: 2.945

Review 5.  The Use of Intravenous Lidocaine in Perioperative Medicine: Anaesthetic, Analgesic and Immune-Modulatory Aspects.

Authors:  Ingrid Wing-Sum Lee; Stefan Schraag
Journal:  J Clin Med       Date:  2022-06-20       Impact factor: 4.964

6.  Effect of lidocaine and ropivacaine on primary (SW480) and metastatic (SW620) colon cancer cell lines.

Authors:  Wiebke Siekmann; Elisabet Tina; Anita Koskela Von Sydow; Anil Gupta
Journal:  Oncol Lett       Date:  2019-05-07       Impact factor: 2.967

7.  Calcium Mobilization and Inhibition of Akt Reduced the Binding of PEO-1 Cells to Fibronectin.

Authors:  Seda Mehtap Sari Kiliçaslan; Aysun Ayrim; Elif Apaydin; Zerrin Incesu
Journal:  Turk J Pharm Sci       Date:  2018-04-02

Review 8.  The Amide Local Anesthetic Lidocaine in Cancer Surgery-Potential Antimetastatic Effects and Preservation of Immune Cell Function? A Narrative Review.

Authors:  Thiên-Nga Chamaraux-Tran; Tobias Piegeler
Journal:  Front Med (Lausanne)       Date:  2017-12-20

9.  Effects of Lidocaine-Mediated CPEB3 Upregulation in Human Hepatocellular Carcinoma Cell Proliferation In Vitro.

Authors:  Hongjun Liu; Yiru Wang; Bing Chen; Xia Shen; Wenxian Li
Journal:  Biomed Res Int       Date:  2018-04-17       Impact factor: 3.411

Review 10.  Local Anesthetic Lidocaine and Cancer: Insight Into Tumor Progression and Recurrence.

Authors:  Caihui Zhang; Cuiyu Xie; Yao Lu
Journal:  Front Oncol       Date:  2021-06-24       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.